Loading...
XSHE002758
Market cap574mUSD
Jan 10, Last price  
8.28CNY
1D
-3.72%
1Q
-4.72%
Jan 2017
-72.06%
IPO
-27.57%
Name

Zhejiang Huatong Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:002758 chart
P/E
11.06
P/S
0.10
EPS
0.75
Div Yield, %
5.66%
Shrs. gr., 5y
18.97%
Rev. gr., 5y
93.16%
Revenues
40.94b
-2.09%
799,315,259952,966,5011,048,455,3171,143,890,0491,219,935,5721,257,977,0441,369,098,1281,522,689,1011,679,074,95928,747,252,78935,143,834,63241,813,272,50240,941,153,868
Net income
381m
-70.09%
44,104,18142,359,28545,411,59645,904,83146,950,67440,155,18442,063,81634,563,26019,700,386780,487,1371,378,737,3461,273,594,530380,944,589
CFO
872m
-55.69%
056,093,79064,599,11178,198,55019,571,4884,549,98023,866,63937,637,83058,622,3731,631,372,8211,378,603,8391,968,797,647872,423,544
Dividend
May 28, 20240.3 CNY/sh
Earnings
May 16, 2025

Profile

Zjamp Group Co., Ltd. engages in the production of pesticides and fertilizers. The company was founded in 1999 and is based in Hangzhou, China.
URL
http://www.znjtgf.com/
IPO date
May 27, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
40,941,154
-2.09%
41,813,273
18.98%
Cost of revenue
39,497,195
39,508,238
Unusual Expense (Income)
NOPBT
1,443,958
2,305,034
NOPBT Margin
3.53%
5.51%
Operating Taxes
257,273
407,765
Tax Rate
17.82%
17.69%
NOPAT
1,186,685
1,897,270
Net income
380,945
-70.09%
1,273,595
-7.63%
Dividends
(238,510)
(150,537)
Dividend yield
4.45%
2.11%
Proceeds from repurchase of equity
(4,617)
BB yield
0.09%
Debt
Debt current
2,436,064
2,467,970
Long-term debt
781,007
937,300
Deferred revenue
39,050
39,109
Other long-term liabilities
9,756
8,508
Net debt
(3,390,295)
(3,299,436)
Cash flow
Cash from operating activities
872,424
1,968,798
CAPEX
(437,820)
Cash from investing activities
(318,750)
506,223
Cash from financing activities
(829,956)
FCF
570,844
2,267,515
Balance
Cash
5,869,365
5,787,479
Long term investments
738,001
917,227
Excess cash
4,560,309
4,614,042
Stockholders' equity
6,249,886
6,052,188
Invested Capital
5,634,775
4,763,772
ROIC
22.82%
37.12%
ROCE
13.75%
24.08%
EV
Common stock shares outstanding
514,790
508,162
Price
10.40
-26.03%
14.06
13.48%
Market cap
5,353,816
-25.07%
7,144,761
15.07%
EV
4,726,949
6,302,657
EBITDA
1,686,581
2,537,177
EV/EBITDA
2.80
2.48
Interest
117,639
111,744
Interest/NOPBT
8.15%
4.85%